Vertex Pharmaceuticals, Inc. (VRTX)
Q2 2012 Earnings Call
July 30, 2012 5:00 p.m. EDT
ExecutivesMichael Partridge – VP, IRJeff Leiden – Chair, President and CEOIan Smith – EVP and CFOPeter Mueller – EVP, Global Research and Development, and Chief Scientific OfficerRobert Kauffman – SVP and Chief Medical OfficerAnalystsGeoff Porges – Sanford BernsteinRachel McMinn – Bank of America-Merrill LynchMark Schoenebaum – ISI GroupYaron Werber – CitigroupGeoff Meacham – JPMorganMatt Roden – UBSLiisa Bayko – JMP SecuritiesTerence Flynn – Goldman SachsTom Russo – Robert W. BairdYing Huang – Barclays CapitalBrian Abrahams – Wells Fargo SecuritiesDavid Friedman – Morgan StanleyKatherine Xu – William BlairHoward Liang – Leerink SwannMichael Yee – RBC Capital MarketsEd Tenthoff – Piper JaffrayPhil Nadeau – Cowen and Co.Brian Skorney – Brean MurrayAlan Carr – Needham & Co.PresentationOperatorGood day, ladies and gentlemen and welcome to Vertex Pharmaceuticals, Incorporated second quarter 2012 financial results conference call.
Previous Statements by VRTX
» Vertex's Management Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript)
» Vertex Pharmaceuticals Incorporated's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Vertex Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
» Vertex Pharmaceuticals' CEO Presents at JPMorgan Global Healthcare Conference (Transcript)
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV